Question special

While primary care physicians have explicit guidelines in screening for many etiologies of cirrhosis (i.e. counseling for alcohol use, obtaining HCV serologies), there are currently no USPSTF guidelines that address screening for NAFLD. Routine screening at this time is not typically recommended due to uncertainties in long-term benefits and cost-effectiveness, however with the rising incidence of NAFLD it will be interesting to see how this paradigm shifts.

Other than encouraging weight loss and discouraging alcohol abuse, what recommendations would you give primary care physicians for their patient population at risk of developing NAFLD in terms of helping prevent progression of liver disease?